Repare Therapeutics (RPTX)
(Delayed Data from NSDQ)
$3.52 USD
+0.02 (0.57%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $3.53 +0.01 (0.28%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.83 | 0.00% |
Earnings Summary
For their last quarter, Repare Therapeutics (RPTX) reported earnings of -$0.82 per share, beating the Zacks Consensus Estimate of $-0.85 per share. This reflects a positive earnings surprise of 3.53%. Look out for RPTX's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.83 per share, reflecting a year-over-year decrease of 84.44%.
Earnings History
Price & Consensus
Zacks News for RPTX
Theravance (TBPH) Q2 Loss Wider Than Expected, Revenues Rise Y/Y
RPTX: What are Zacks experts saying now?
Zacks Private Portfolio Services